NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 82 filers reported holding NATERA INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,494,412 | -32.5% | 33,772 | -25.8% | 0.00% | 0.0% |
| Q2 2023 | $2,215,295 | -57.2% | 45,526 | -51.2% | 0.00% | -50.0% |
| Q1 2023 | $5,177,296 | +0.1% | 93,251 | -27.6% | 0.00% | 0.0% |
| Q4 2022 | $5,172,932 | +114.1% | 128,776 | +133.5% | 0.00% | +100.0% |
| Q3 2022 | $2,416,000 | +67.8% | 55,154 | +35.8% | 0.00% | 0.0% |
| Q2 2022 | $1,440,000 | -70.8% | 40,624 | -66.5% | 0.00% | -50.0% |
| Q1 2022 | $4,936,000 | +155.8% | 121,329 | +487.1% | 0.00% | +100.0% |
| Q4 2021 | $1,930,000 | -56.9% | 20,665 | -48.6% | 0.00% | 0.0% |
| Q3 2021 | $4,478,000 | -21.6% | 40,184 | -20.1% | 0.00% | -50.0% |
| Q2 2021 | $5,713,000 | +53.7% | 50,322 | +37.4% | 0.00% | +100.0% |
| Q1 2021 | $3,718,000 | -27.4% | 36,620 | -28.9% | 0.00% | -50.0% |
| Q4 2020 | $5,123,000 | +386.1% | 51,477 | +252.7% | 0.00% | – |
| Q3 2020 | $1,054,000 | -3.3% | 14,595 | -33.2% | 0.00% | – |
| Q2 2020 | $1,090,000 | +300.7% | 21,861 | +140.5% | 0.00% | – |
| Q1 2020 | $272,000 | -1.8% | 9,089 | +10.5% | 0.00% | – |
| Q4 2019 | $277,000 | -95.0% | 8,226 | -95.1% | 0.00% | -100.0% |
| Q3 2019 | $5,494,000 | +112.2% | 167,480 | +78.4% | 0.00% | +100.0% |
| Q2 2019 | $2,589,000 | +3306.6% | 93,865 | +2453.5% | 0.00% | – |
| Q1 2019 | $76,000 | -97.1% | 3,676 | -98.1% | 0.00% | -100.0% |
| Q4 2018 | $2,663,000 | +77.2% | 190,759 | +203.8% | 0.00% | 0.0% |
| Q3 2018 | $1,503,000 | +816.5% | 62,798 | +619.6% | 0.00% | – |
| Q2 2018 | $164,000 | +1161.5% | 8,727 | +503.1% | 0.00% | – |
| Q1 2018 | $13,000 | -66.7% | 1,447 | -66.6% | 0.00% | – |
| Q4 2017 | $39,000 | -23.5% | 4,333 | +9.9% | 0.00% | – |
| Q3 2017 | $51,000 | +10.9% | 3,944 | -7.7% | 0.00% | – |
| Q2 2017 | $46,000 | +155.6% | 4,273 | +114.2% | 0.00% | – |
| Q1 2017 | $18,000 | -72.7% | 1,995 | -64.7% | 0.00% | – |
| Q4 2016 | $66,000 | +200.0% | 5,656 | +178.6% | 0.00% | – |
| Q3 2016 | $22,000 | +57.1% | 2,030 | +69.2% | 0.00% | – |
| Q2 2016 | $14,000 | +600.0% | 1,200 | +500.0% | 0.00% | – |
| Q1 2016 | $2,000 | -93.3% | 200 | -92.8% | 0.00% | – |
| Q4 2015 | $30,000 | +1400.0% | 2,793 | +1296.5% | 0.00% | – |
| Q3 2015 | $2,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |